A new therapy targeting “gluttonous” prostate cancer cells

    NAME A/Prof. Jeff Holst
    CANCER TYPE Prostate cancer
    INSTITUTION University of New South Wales
    STATE New South Wales
    GRANT TYPE $200,000
    PROJECT TYPE Research

    A new therapy targeting “gluttonous” prostate cancer cells

    "We have characterised a new target, ASCT2, which is highly expressed in prostate cancer, and demonstrated that targeting ASCT2 decreases the growth of prostate cancer cells in the laboratory, and in animal models. In this study we will test this compound in a preclinical model using 50 patient tumour samples grown immediately from prostate cancer surgery as an explant."

    - A/Prof. Jeff Holst, University of New South Wales